Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
NCT00076375
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Eczema
Interventions
DRUG:
Nanocrystalline silver cream (NPI)
Sponsor
Nucryst Pharmaceuticals